ReviewBlood cancer journal2021
Ibrutinib combinations in CLL therapy: scientific rationale and clinical results.
Natalia Timofeeva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papertrialcites it
ReviewBlood cancer journal2021
Natalia Timofeeva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.